Medtronic (NYSE: MDT) hits 10-year high growth before Oct. 15 vote

Medtronic (NYSE: MDT) is asking shareholders to vote on six key proposals at its Annual General Meeting on October 15, 2026, following a fiscal year (FY26) marked by strong financial performance. The company reported $36.4 billion in revenue, an 8.4% reported increase and 5.8% organic growth over FY25, which represents its strongest top-line performance in a decade. Medtronic also generated $5.4 billion in free cash flow and returned $4.2 billion to shareholders through dividends and share repurchases, while advancing strategic initiatives like the IPO of its Diabetes business, MiniMed, and establishing new Board committees for growth and operations.